WOCKHARDT GETS USFDA NOD

Search News

Pharma major Wockhardt has said that it has received approval from the US drug regulator for marketing its antiepileptic tablet Levetiracentam in that country. The company has received approval from the United States Food & Drug Administration (USFDA) for marketing of Levetiracentam tablets in the strength of 250, 500, 750 mg and 1 gm, Wockhardt said in a filing to the Bombay Stock Exchange. Levetiracentam tablets are used in the treatment of various kinds of epileptic seizures.

Find Lawyer / Law Firm

Importance of Immigration Lawyers

As Indians we know India in itself is an amazing nation and even the world agrees with that, however, grass is always greener on the other side and that is why Indians desire to immigrate a More

Legal Consultation - Consult over phone, chat or send questions

Helplinelaw can set up your session with quality and experienced lawyers to discuss and resolve your legal matters. You can avail consultation in form of sending questions, phone call or webchat discussion  More